EL · Q4 2026 Earnings

Bullish

Estée Lauder Companies (The)

Reported August 19, 2026

30-second summary

Estée Lauder closed FY26 at 3% organic growth, $2.51 non-GAAP EPS, and 11.2% adjusted operating margin — beating the top end of every guide raised at Q3 (EPS $2.35–$2.45; margin 10.7–11.0%) and delivering exactly on "approximately 3%" organic. Management responded by raising FY27 adjusted operating margin to 12.7–13.5% (from the preliminary 12.5–13.0% floated in Q3), affirming 3–5% organic, and issuing an FY27 non-GAAP EPS range of $3.10–$3.35 — a 23–33% YoY step-up. The turnaround is now a two-year, 470bps margin story with the compounding leg formalized on time.

Headline numbers

EPS

Q4 FY2026

$2.51

Revenue

Q4 FY2026

$15.05B

+5.0% YoY

Gross margin

Q4 FY2026

75.5%

Free cash flow

Q4 FY2026

$1.32B

Operating margin

Q4 FY2026

5.2%

Key financials

Q4 FY2026

Metric	Q4 FY2026	Q4 FY2025	YoY	Q3 FY2026	QoQ
Revenue	$15.05B	$14.33B	+5.0%	$3.71B	+305.4%
EPS	$2.51	$1.51	+66.2%	$0.91	+175.8%
Gross margin	75.5%	74.0%	+150bps	76.4%	-90bps
Operating margin	5.2%	-5.5%	+1070bps	6.7%	-150bps
Free cash flow	$1.32B	$0.67B	+97.6%	—	—

Guidance

Company raised FY2027 adjusted operating margin guidance by 20–50 basis points to 12.7%–13.5% while maintaining organic growth outlook of 3–5%, demonstrating confidence in PRGP benefits; FY2026 results beat EPS and margin guides.

Guidance is issued for both next quarter and the full year. Both may appear below.

Actuals vs prior guidance

Metric	Period	Prior guide	Actual	Δ	Result
Non-GAAP EPS	FY2026	$2.35 to $2.45	$2.51	+$0.06 to $0.16 above guide	Beat
Organic Net Sales Growth	FY2026	approximately 3%	3%	in-line	Met
Adjusted Operating Margin	FY2026	10.7% to 11.0%	11.2%	+0.2 to +0.5 pts above guide	Beat

New guidance

Metric	Period	Guide	YoY
Non-GAAP EPS	FY2027	$3.10 to $3.35	+23.5% to +33.5% YoY
Adjusted Constant Currency EPS	FY2027	$3.06 to $3.31	+21.9% to +31.9% YoY

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
Organic Net Sales Growth	FY2027	3% to 5%	3% to 5%	reaffirmed (range matches prior preliminary view)	Raised
Adjusted Operating Margin	FY2027	12.5% to 13.0%	12.7% to 13.5%	+0.2 to +0.5 pts raised	Raised

Segment performance

Q4 FY2026

Segment	Q4 FY2026	Q4 FY2025	YoY
Skin Care	$7.338B	$6.962B	+5.4%
Fragrance	$2.779B	$2.491B	+11.6%
Makeup	$4.276B	$4.205B	+1.7%
Hair Care	$0.565B	$0.565B	+0.0%

Platform metrics

Q4 FY2026

Segment	Q4 FY2026	Q4 FY2025	YoY
Organic Net Sales Growth (Full Year)	3%	—	—
Billion-Dollar Brands	6 brands	—	—
Innovation as % of Sales	23%	—	—
Consumer-Facing Investments Growth	7% (reported), 4% (organic)	—	—
PRGP Restructuring Gross Benefits	$1.2 billion (at high-end)	—	—
Net Position Reduction from PRGP	10,000 positions (at high-end)	—	—

Profitability

Q4 FY2026

Segment	Q4 FY2026	Q4 FY2025	YoY
Adjusted Operating Margin (Full Year)	11.2%	—	—
Free Cash Flow	$1.32 billion	—	—

Other KPIs

Q4 FY2026

Segment	Q4 FY2026	Q4 FY2025	YoY
Mainland China	$3.058B	—	+9.0%
The Americas	$4.463B	$4.411B	+1.2%
EUKEM	$3.794B	—	+1.0%
Asia/Pacific	$3.746B	$4.537B	-17.4%

Management tone

Q1 recovery sighting → Q2 "going for top end" → Q3 FY27 preliminary preview → Q4 FY27 formalized with margin raise.

Tone analysis without transcript is limited to press-release language; the shifts below are drawn from prepared-remarks quotes in the release.

Three quarters ago the FY27 outlook did not exist as a disclosure. Two quarters ago Stéphane de La Faverie floated a "preliminary view" of 12.5–13.0%. This quarter the range was formalized and raised: "we are affirming our confidence to accelerate organic sales growth" and "raising our outlook for an even stronger adjusted operating margin." The escalation from preliminary view to affirmed-and-raised in a single quarter, without waiting for a Q1 FY27 print, is the largest posture shift on the release. Preliminary views typically get narrowed or widened on the formalizing print; raising one is a distinct commitment.

Two quarters ago geographic strength was concentrated in Mainland China; last quarter management flagged Asia/Pacific turning -1% as the first regional negative print of the turnaround. This quarter the FY27 language explicitly names "accelerating growth in North America" as a diversification priority. The rebalance signals management is no longer willing to depend on China as the sole growth engine — a defensible posture given China printed +9% for the year but decelerated from Q2 to Q3, and given the Americas at +1% for the full year has meaningful room to inflect if North American execution lands.

Three quarters ago PRGP was described as savings to be reinvested; two quarters ago as the funder of "first margin expansion in four years"; last quarter as "a P&L built for leverage." This quarter the release quantified it: $1.2B gross benefits, 10,000 net position reductions, "vast majority of the full run-rate benefits still expected to be realized during fiscal 2027." Putting specific numbers and a specific delivery window on the record is the cleanest evidence that PRGP has moved from strategic frame to operating machinery — and the FY27 margin raise is the arithmetic consequence.

Answers to last quarter's watch list

Q4 FY26 EPS landing within $2.35–$2.45 absorbing the Middle East $0.06 hit: FY26 non-GAAP EPS printed at $2.51, $0.06 above the high end of the raised range. Implied Q4 non-GAAP EPS is ~$0.71 (versus the H1 build of $0.32 + $0.89 + $0.91 Q3 = $2.12 through nine months). The Middle East impact was absorbed and the FY still cleared the top of the band.

Resolved positively

Q4 organic growth holding ≥2% to validate "approximately 3% FY": FY26 organic net sales landed at +3%, matching the "approximately 3%" guide exactly. Given Q1 +3%, Q2 +4%, Q3 +2% and the FY at +3%, Q4 organic must have printed near +3% — well above the "+1% or less" scenario the Q3 watch flagged. The 2pt Middle East headwind did not force reliance on the optical line.

Resolved positively

Skin care turning positive again after a flat Q3: FY26 skin care landed at +4% organic. With Q1 +3%, Q2 +6%, Q3 flat, Q4 must have printed positive mid-single-digits to average +4% for the year. The keystone category re-accelerated in Q4 and the FY27 3–5% sales preview is now sitting on top of a confirming print.

Resolved positively

Mainland China holding mid-single-digit with discount discipline: Mainland China at +9% organic for the full year, with Q4 implicitly above +6% to arithmetic to +9% given the Q1–Q3 trajectory (+9%, +13%, +6%). The mid-single-digit floor is well cleared. The specific "discount discipline" qualitative language from Q2 was not refreshed in this press release, which is the one soft spot on the China line; the quantitative outcome is unambiguously positive.

Resolved positively

FY27 preliminary guide refinement at the August Q4 print: Sales range held at 3–5%; margin range raised to 12.7–13.5% (from 12.5–13.0%) — narrowed-and-raised, not widened. Department-store door-exit math was not quantified in the release. The FY27 outlook was formalized ahead of schedule with a margin raise, and EPS guidance ($3.10–$3.35) was added as a new disclosure.

Resolved positively

Tariff and operating cash flow disclosure: Neither reinstated. Tariff has now been absent for three consecutive quarters; operating cash flow forward band has been absent for four. FY26 free cash flow was disclosed as $1.32B (an actual), but no FY27 forward cash guide was issued. With FY27 EPS and margin guidance now on the record, the continued silence on cash conversion and tariff is asymmetric to the direction of every other update.

Resolved negatively

What to watch into next quarter

Q1 FY27 organic growth against the 3–5% FY band: Q1 FY26 baseline is $3.48B and printed +3% organic. Management flagged "greater increase in the first half compared to the second" for FY27, so Q1 organic needs to land at the high end of the 3–5% range (i.e. closer to +5%) to validate the H1-weighting; a Q1 print at +2% or below would force H2 to accelerate meaningfully to hit even the low end.

North America inflection from +1% FY26 toward accelerating growth: management named North America as the FY27 diversification priority. Watch whether the Americas region prints +2% or better in Q1 FY27, and whether department-store door-exit math finally gets quantified in prepared remarks.

PRGP FY27 delivery cadence: $1.2B gross benefits and 10,000 net position reductions frame the run-rate expectation. Watch whether Q1 FY27 adjusted operating margin lands above the FY26 Q1 comparison of 7.3% by a wide margin — the "vast majority in FY27" framing implies front-loaded margin delivery.

Makeup finally crossing zero: the category has printed -2% → -1% → flat → flat → FY flat across five prints. A Q1 FY27 positive makeup print would validate the MAC/Sephora and TikTok Shop levers management put on the record two quarters ago; another flat-or-negative print starts to challenge the FY27 category diversification thesis.

Tariff and OCF disclosure with a full FY27 guide live: three quarters of tariff silence and four of OCF silence coexist with a formalized FY27 EPS band. Reinstating either at the Q1 FY27 print would be a constructive transparency signal; continued silence at that point would confirm the withdrawals are structural.

Mainland China discount-discipline language returning: the +9% FY26 organic outcome cleared the mid-single-digit floor, but the "falling discounts" qualitative frame that defined the Q2 China thesis has not been refreshed for two quarters. Watch whether the Q1 FY27 print restates the promotional-intensity claim or leaves the quality-of-growth question open.

Sources

Estée Lauder Q4 and FY2026 Press Release, Exhibit 99.1 — https://www.sec.gov/Archives/edgar/data/1001250/000100125026000038/elq4fy2026exhibit991.htm
Prior briefs: EL Q3 FY2026 (Tapebrief, 2026-05-01); EL Q2 FY2026 (Tapebrief, 2026-02-05); EL Q1 FY2026 (Tapebrief, 2025-10-30); EL Q4 FY2025 (Tapebrief, 2025-08-20).

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.